206 related articles for article (PubMed ID: 12948417)
1. [PTEN coding product: a marker for tumorigenesis and progression of endometrial carcinoma].
Gao QL; Ye F; Li J; Xing H; Lu YP; Ma D
Ai Zheng; 2003 Jun; 22(6):640-4. PubMed ID: 12948417
[TBL] [Abstract][Full Text] [Related]
2. [Detection of mutation and protein expression of PTEN gene in endometrial carcinoma].
Xu B; Yao Q; Dai SZ
Ai Zheng; 2004 Jan; 23(1):69-73. PubMed ID: 14720379
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
[TBL] [Abstract][Full Text] [Related]
4. PTEN and p53 abnormalities are indicative and predictive factors for endometrial carcinoma.
Inaba F; Kawamata H; Teramoto T; Fukasawa I; Inaba N; Fujimori T
Oncol Rep; 2005 Jan; 13(1):17-24. PubMed ID: 15583796
[TBL] [Abstract][Full Text] [Related]
5. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
[TBL] [Abstract][Full Text] [Related]
6. [Study of the mutation and expression of PTEN gene in endometrial carcinoma and epithelial ovarian cancer].
Che Y; Yao Q; Dai S; Luo B; Wang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):608-11. PubMed ID: 12487936
[TBL] [Abstract][Full Text] [Related]
7. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C
J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828
[TBL] [Abstract][Full Text] [Related]
8. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
9. Correlation between NDRG1 and PTEN expression in endometrial carcinoma.
Chen J; Li S; Yang Z; Lu G; Hu H
Cancer Sci; 2008 Apr; 99(4):706-10. PubMed ID: 18377423
[TBL] [Abstract][Full Text] [Related]
10. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
13. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
14. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
15. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
16. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
17. Changes in endometrial PTEN expression throughout the human menstrual cycle.
Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Eng C
J Clin Endocrinol Metab; 2000 Jun; 85(6):2334-8. PubMed ID: 10852473
[TBL] [Abstract][Full Text] [Related]
18. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
Chen Y; Zheng H; Yang X; Sun L; Xin Y
Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
[TBL] [Abstract][Full Text] [Related]
20. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.
Lee H; Choi HJ; Kang CS; Lee HJ; Lee WS; Park CS
Mod Pathol; 2012 Nov; 25(11):1508-15. PubMed ID: 22766795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
